Dextrose injections for failed back surgery syndrome: a consecutive case series

Area of Science:

• Regenerative medicine
• Musculoskeletal disorders
• Pain management

Background:

• Chronic low back pain often leads to surgical interventions.
• Failed back surgery syndrome (FBSS) is a challenging complication of spinal surgery.
• Conservative treatments may be insufficient for persistent back pain post-surgery.

Purpose of the Study:

• To evaluate the efficacy of 5% dextrose prolotherapy for treating failed back surgery syndrome (FBSS).
• To assess the impact of dextrose injections on pain and functional outcomes in FBSS patients.
• To explore dextrose prolotherapy as a potential regenerative treatment for FBSS.

Main Methods:

• A consecutive case series of 79 patients with FBSS.
• Inclusion criteria: minimum 6 months of symptoms, failed 3 months of conservative treatment.
• Treatment involved posterior and lateral dextrose prolotherapy injections.
• Outcomes measured using Visual Analog Scale (VAS) and Oswestry Disability Index (ODI).
• Patient satisfaction assessed via a 5-point Likert scale.

Main Results:

• Statistically significant reductions in Visual Analog Scale (VAS) pain scores were observed.
• Significant improvements in Oswestry Disability Index (ODI) scores indicated reduced disability.
• Patient-reported satisfaction indicated a positive response to the treatment.

Conclusions:

• 5% dextrose prolotherapy shows promise as a treatment for failed back surgery syndrome (FBSS).
• This regenerative approach may offer a viable alternative to revision surgery for FBSS.
• Further research is warranted to explore this novel treatment in an undiscovered field.